Deep Space Therapeutics
Healing this World and the Next...
Deep Space Therapeutics
Healing this World and the Next...
About Deep Space Therapeutics
Our Innovative Therapies
Innovation is at the heart of what we do. We are developing nanoencapsulation methods and creating diseased cell lines for next generation drugs in Parkinson's, MS, IRDs, and beyond...
Our Team
Our team includes scientists, researchers, engineers, and business professionals, all of whom bring unique skills and perspectives to our research.
Innovative healing Solutions ready now!
Rapid Repair Wound Dressing
Rapid Repair Wound Dressing
Rapid Repair Wound Dressing
We're ready to heal wounds in all animals. Pre-order our 'Rapid Repair Wound Dressing' today. Find out how horse wounds are healing faster than ever!
Enhanced Wound healing
Rapid Repair Wound Dressing
Rapid Repair Wound Dressing
Our team of experts works on rapid wound healing solutions. FDA approval of Rapid Repair bandage in humans coming soon!
Our research Areas
Stem Cell Biology
Stem Cell Biology
Stem Cell Biology
Growing iPSCs & organoids in deep space for next generation drugs remains an adamant component for the Artemis Program at NASA. Explore stem cell scaffolds and organoid development.
Genomic Editing
Stem Cell Biology
Stem Cell Biology
Learn how we can target over 90% of inherited diseases through Prime Editing. Explore the potential for genome editing of human cells and plants.
Drug Developement
Stem Cell Biology
Drug Developement
Developing drugs is vital for all galactic endeavors to prevent complex neurological conditions. This is for sustained Earth presence & beyond.
Timeline of DST
Stealth Mode for DST - November 2022
Deep in the mountains of the Northeast, our CEO, Dr. Miller, envisioned DST while hiking and escaping lab life.
DST Founded - December 2023
Following Chris's postdoc and work as a 'Sr. Field Application Scientist', he knew it was time to take the leap of faith... We're proud to say we are the FIRST commercialization company in history focused on therapeutic drug development in deep space.
NSF letter received - April 2024
DST receives letter of support from the National Science Foundation in 'Biomedical Technologies' for the SBIR/STTR program. They requested we submit a full 'Phase 1 Proposal'!
Website launched - July 2024
After establishing 4 partners and developing a highly skilled research team, DST unveils first website.
The future...
Laboratorial operations will commence in a 5K sq. ft. facility in western Massachusetts and/or Wilmington, Delaware. Coming soon!
Our Partners
